Clinical Trial Detail

NCT ID NCT00378638
Title Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer
Recruitment Unknown status
Gender female
Phase Phase II
Variant Requirements No
Sponsors Chap, Linnea I., M.D.
Indications

breast cancer

Therapies

Bevacizumab

Age Groups: adult

No variant requirements are available.